R
Remo G. Lobetti
Researcher at University of Pretoria
Publications - 61
Citations - 1912
Remo G. Lobetti is an academic researcher from University of Pretoria. The author has contributed to research in topics: Renal function & Creatinine. The author has an hindex of 25, co-authored 61 publications receiving 1723 citations.
Papers
More filters
Journal ArticleDOI
Prognostic value of blood lactate, blood glucose, and hematocrit in canine babesiosis
TL;DR: It is concluded that serial blood lactate measurements are useful in predicting survival in dogs with severe and complicated canine babesiosis.
Journal ArticleDOI
Cardiac Troponins in Canine Babesiosis
TL;DR: It was concluded that the analysis of plasma cTnI is a feasible and sensitive test and is superior tocTnT in diagnosing cardiac involvement in dogs with babesiosis and no correlation between ECG abnormalities and histological changes or biochemical evidence of myocardial damage as reflected by cTNI concentrations was shown.
Journal ArticleDOI
Canine babesiosis in South Africa: more than one disease. Does this serve as a model for falciparum malaria?
TL;DR: A retrospective survey of 662 hospitalized cases revealed that the haematology, clinical biochemistry and patient profile (signalment) of the severely anaemic dogs were distinct from those of the non-anaemic, indicating that the babesiosis in these two groups of dogs should be viewed as two different disease in terms of the postulated, underlying, 'pathomechanisms'.
Journal ArticleDOI
Phylogenetic Analysis of Hemoplasma Species: an International Study
Séverine Tasker,Christopher R Helps,Michael J. Day,David A. Harbour,Se Shaw,Shimon Harrus,Gad Baneth,Remo G. Lobetti,Richard Malik,J Beaufils,CR Belford,Timothy J Gruffydd-Jones +11 more
TL;DR: Nearly complete 16S rRNA gene sequences for feline and canine hemoplasma isolates from Europe, Australia, Africa, and Asia showed almost 100% identity to those previously reported for United States isolates, and phylogenetic analysis showed that the hemoplasmas are most closely related to the members of the Mycoplasma pneumoniae group.
Journal ArticleDOI
International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study.
Philip R. Fox,Bruce W. Keene,Kenneth E. Lamb,Karsten A. Schober,Valérie Chetboul,Virginia Luis Fuentes,Gerhard Wess,Jessie Rose Payne,Daniel F. Hogan,Alison A. Motsinger-Reif,Jens Häggström,Emilie Trehiou-Sechi,Deborah M. Fine-Ferreira,Reid K. Nakamura,Pamela M. Lee,Manreet K. Singh,Wendy A. Ware,Jonathan A. Abbott,Geoffrey Culshaw,Sabine Riesen,M. Borgarelli,Michael B. Lesser,Nicole Van Israël,Etienne Côté,John E. Rush,Barret J. Bulmer,Roberto A. Santilli,Andrea Vollmar,Maribeth J. Bossbaly,Nadine Quick,Claudio Bussadori,Janice M. Bright,Amara H. Estrada,Dan G. Ohad,María Josefa Fernández del Palacio,Jenifer Lunney Brayley,Denise Saretta Schwartz,Christina M. Bové,Sonya G. Gordon,Seung Woo Jung,Paola Brambilla,N. Sydney Moïse,Christopher D. Stauthammer,Rebecca L. Stepien,C. Quintavalla,Christophe Amberger,Ferenc Manczur,Yong Wei Hung,Remo G. Lobetti,Marie de Swarte,A. Tamborini,Carmel T. Mooney,Mark A. Oyama,Andrey Komolov,Yoko Fujii,Romain Pariaut,Masami Uechi,Victoria Yukie Tachika Ohara +57 more
TL;DR: Preclinical HCM/HOCM is a global health problem of cats that carries substantial risk for CHF, ATE, and cardiovascular death, and this finding underscores the need to identify therapies and monitoring strategies that decrease morbidity and mortality.